15.10
+0.60
+(4.10%)
At close: January 31 at 8:16:34 AM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-179,425.00
-145,929.00
-145,060.00
287,959.00
-134,828.00
Investing Cash Flow
249,154.00
-205,686.00
-182,734.00
-67,387.00
-9,484.00
Financing Cash Flow
-52,923.00
362,721.00
1,445.00
94,858.00
7,444.00
End Cash Position
249,442.00
244,544.00
231,173.00
559,353.00
247,680.00
Interest Paid Supplemental Data
20,774.00
16,878.00
9,247.00
6,539.00
4,131.00
Capital Expenditure
-13,666.00
-7,154.00
-17,688.00
-17,438.00
-9,484.00
Issuance of Capital Stock
127.00
308.00
1,445.00
33,697.00
7,444.00
Issuance of Debt
-374,350.00
--
--
64,067.00
--
Repayment of Debt
-53,050.00
--
--
-1,572.00
--
Free Cash Flow
-193,091.00
-153,083.00
-162,748.00
270,521.00
-144,312.00
12/31/2020 - 12/8/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NUZ.AX Neurizon Therapeutics Limited
0.1250
0.00%
1VT.BE Viking Therapeutics Inc
31.59
-1.83%
CNTB Connect Biopharma Holdings Limited
0.9720
-3.76%
COYA Coya Therapeutics, Inc.
6.08
+3.75%
BCAX Bicara Therapeutics Inc.
12.62
-2.25%
CAMP CAMP4 THERAPEUTICS CORPORATION
4.8100
-18.47%
CDXS Codexis, Inc.
4.1900
-6.89%
DTIL Precision BioSciences, Inc.
5.01
-3.84%
TRAW Traws Pharma, Inc.
7.28
+0.83%
JAZZ Jazz Pharmaceuticals plc
124.37
-0.54%